Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19

Author:

Andreakos Evangelos12ORCID,Papadaki Maria1,Serhan Charles N.3

Affiliation:

1. Laboratory of Immunobiology Center for Clinical, Experimental Surgery and Translational Research Biomedical Research Foundation of the Academy of Athens Athens Greece

2. Airway Disease Infection Section National Heart and Lung Institute Imperial College London London UK

3. Department of Anesthesiology, Perioperative and Pain Medicine Brigham and Women's Hospital Harvard Medical School Center for Experimental Therapeutics and Reperfusion Injury Boston MA USA

Funder

Hellenic Foundation for Research and Innovation

H2020 Energy

H2020 Future and Emerging Technologies

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference16 articles.

1. Clinical Characteristics of Coronavirus Disease 2019 in China

2. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

3. Pharmacologic treatments for coronavirus disease 2019 (COVID‐19): A Review;Sanders JM;JAMA,2020

4. Dexamethasone in Hospitalized Patients with Covid‐19 ‐ Preliminary Report;Horby P;N Engl J Med,2020

5. Glucocorticoid receptor control of transcription: precision and plasticity via allostery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3